Submission Guidelines
International Journal of Clinical Pharmacy and Medicine welcomes original research articles, reviews, systematic reviews, meta-analyses, brief reports, case reports, commentaries, and letters to the editor in the field of clinical pharmacy and medicine.
Manuscript Preparation
- Manuscripts should be written in clear, concise English.
- Use double-spacing throughout the manuscript.
- Include a structured abstract (Background, Methods, Results, Conclusion) of up to 300 words.
- Provide 3-6 keywords below the abstract.
- Follow AMA (American Medical Association) citation style.
- Submit manuscripts in PDF or DOCX format.
Formatting Requirements
- Title page: Include full title, all author names, affiliations, and corresponding author contact details.
- Abstract: Structured abstract with a maximum of 300 words.
- Main text: Introduction, Methods, Results, Discussion, Conclusion.
- References: Numbered consecutively in order of appearance, using AMA style.
- Tables and Figures: Include at the end of the manuscript with clear captions.
How to Submit
- Prepare your manuscript following the guidelines above.
- Prepare a cover letter addressed to the Editor-in-Chief.
- Go to our <a href="https://ijcpm.com/submit-manuscript/">Submit Manuscript</a> page.
- Fill in the submission form with your details and upload your files.
- You will receive a confirmation email with your submission ID.
Peer Review Process: All submitted manuscripts undergo rigorous double-anonymized peer review. The editorial decision is typically communicated within 4-6 weeks of submission.
Fees and Funding
An article processing charge (APC) applies for each article accepted for publication in International Journal of Clinical Pharmacy and Medicine. The APC price will be determined from the date on which the article is accepted for publication.
The current APC for International Journal of Clinical Pharmacy is $50.
This fee is subject to VAT or local taxes where applicable.
Ethical Requirements & Declarations
- All studies involving human participants must have prospective ethics committee / Institutional Review Board (IRB) approval.
- Written informed consent must be obtained from study participants or their authorized representatives.
- All authors must disclose any financial or non-financial conflicts of interest.
- Submissions must represent original work and not be under consideration by any other journal simultaneously.
- Mandatory disclosure of any generative AI or AI-assisted technologies used during manuscript preparation.
- All submissions undergo automated similarity screening prior to peer review.